Immunogen (IMGN) Director Buys 20K Shares
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) Director, Mark Alan Goldberg, bought 20,000 shares on 12/15 at $1.80
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX Shares Indicated To Open At $155
- This staples stock "is well positioned from a cost/pricing standpoint": Morgan Stanley
- Earnings could be a positive catalyst for this stock: UBS
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
